Bellemin Jean-Marc (CIK 1754253) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-06-04). Recent activity: Buy IOVA (8,789 shares), Sell IOVA (4,464 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-06-04 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Chief Financial Officer | Buy | 8,789 | $0 |
| 2025-06-04 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Chief Financial Officer | Sell | 4,464 | $7,857 |
来源：SEC Form 4 申报文件 · 截至 2025-06-04